163
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

What do Spanish women know about menopause? COMEM study

ORCID Icon, ORCID Icon, , ORCID Icon, , & show all

References

  • Alfred A, Esterman A, Farmer E, Pilotto L, Weston K. 2006. Women’s decision making at menopause a focus group study. Australian Family Physician 35:270–272.
  • Baquedano L, Espiau A, Fasero M, Ortega S, Ramirez I, Mendoza N, COMEM Study Spanish investigators, et al. 2020. Beliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM-treatment study. BMC Women's Health 20:277.
  • Cornellana MJ, Harvey X, Carballo A, Khartchenko E, Llaneza P, Palacios S, MUMENESP Group, et al. 2017. Sexual health in Spanish postmenopausal women presenting at outpatient clinics. Climacteric : The Journal of the International Menopause Society 20:164–170.
  • Currie H, Moger SJ. 2019. Menopause – understanding the impact on women and their partners. Post Reprod Health 25:183–190.
  • Depypere H, Pintiaux A, Desreux J, Hendrickx M, Neven P, Marchowicz E, et al. 2016. Coping with menopausal symptoms: an internet sur- vey of Belgian postmenopausal women. Maturitas 90:24–30.
  • Fasero M, Mainar LB, Campo LR, Delgado DV, Coronado PJ. 2020. What do Spanish men know about menopause? Menopause 27:1047–1052.
  • García Padilla FM, López Santos V, Toronjo Gómez AM, Toscano Márquez T, Contreras Martín A. 2000. Valoración de conocimientos sobre el climaterio en mujeres andaluzas. Atención Primaria 26:476–481.
  • Harun MGD, Salema U, Chowdhury A, Haque MI, Kafi MAH, Shahajahan M, et al. 2020. Knowledge and attitudes associated with menopause among women aged 45 to 60 years: a pilot study among rural and urban women in Bangladesh. Menopause 27:648–657.
  • Kim MK, Seo SK, Chae HD, Hwang KJ, Kim T, Yoon BK, et al. 2017. Perceptions of postmenopausal symptoms and treatment options among middle-aged Korean women. Yonsei Medical Journal 58:533–539.
  • Kingsberg SA, Wysocki S, Magnus L, Krychman ML. 2013. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. The Journal of Sexual Medicine 10:1790–1799.
  • Larroy C, Marin Martin C, Lopez-Picado A, Fernández Arias I. 2020. The impact of perimenopausal symptomatology, sociodemographic status and knowledge of menopause on women's quality of life. Archives of Gynecology and Obstetrics 301:1061–1068.
  • Mendoza N, Hernández C, Cornellana MJ, Carballo A, Llaneza P, Harvey X, MUMENESP Group, et al. 2016. Factors determining the use of hormonal therapy and phytotherapy in Spanish postmenopausal women. Climacteric 19:375–380.
  • Mendoza N, Juliá MD, Galliano D, Coronado P, Díaz B, Fontes J, et al. 2015. Spanish consensus on premature menopause. Maturitas 80:220–225.
  • Pacello P, Baccaro LF, Pedro AO, Costa-Paiva L. 2018. Prevalence of hormone therapy, factors associated with its use, and knowledge about menopause: a population-based household survey. Menopause 25:683–690.
  • Ruiz I, Bermejo MJ. 2004. Conocimiento de las mujeres menopáusicas respecto a la terapia hormonal sustitutiva. Gaceta Sanitaria 18:32–37.
  • Sanchez-Borrego R, Molero F, Castaño R, Castelo-Branco C, Honrado M, Jurado AR, et al. 2014. Spanish consensus on sexual health in men and women over 50. Maturitas 78:138–145.
  • Sánchez Borrego R, Llaneza Coto P, Mendoza Ladrón de Guevara N, et al. 2018. AEEM-SEGO position statement on menopausal hormone therapy. Progr Obstet Ginecol 61:230–234.
  • Shifren JL, Gass ML, NAMS Recommendations for Clinical Care of Midlife Women Working Group 2014. The North American Menopause Society recommendations for clinical care of midlife women. Menopause 21:1038–1062.
  • Simon JA, Archer DF, Kagan R, Bernick B, Graham S, Constantine GD, et al. 2017. Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial. Menopause 24:1003–1010.
  • Sveinsdóttir H, Olafsson RF. 2006. Women's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative study. Journal of Advanced Nursing 54:572–584.
  • Tao M, Teng Y, Shao H, Wu P, Mills EJ. 2011. Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis. PLoS One 6:e24661.
  • The NAMS. 2017. Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 24:728–753.
  • Tserotas K, Hernandez L, Morera F, Pineda R, Chedraui P. 2011. Treat- ment for the menopause in Central America: use, knowledge, per- ceptions and attitudes among urban living middle-aged women. Gynecological Endocrinology 27:504–511.
  • Utian WH, Schiff I. 2018. NAMS-gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause 25:1172–1179.
  • Villa P, Tagliaferri V, Amar ID, Cipolla C, Ingravalle F, Scambia G, et al. 2020. Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: efficacy and safety of long-term treatment. Gynecological Endocrinology 36:535–539.
  • de Villiers TJ, Hall JE, Pinkerton JV, Pérez SC, Rees M, Yang C, et al. 2016. Revised global consensus statement on menopausal hormone therapy. Maturitas 91:153–155.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.